Fluorescein-guided intraoperative endoscopy in patients with hereditary hemorrhagic telangiectasia: first impressions

Fabio Pagella, Alessandro Pusateri, Dario Zaccari, Daniele Bongetta, Cesare Zoia, Giuseppe Spinozzi, Carla Olivieri, Elina Matti

Research output: Contribution to journalArticle

2 Citations (Scopus)

Abstract

Background: Hereditary hemorrhagic telangiectasia (HHT) is a rare genetic disease that results in mucocutaneous telangiectasias and arteriovenous visceral malformations. Nasal telangiectasias lead to recurrent epistaxis, which affects up to 96% of patients. Different morphologic classifications and methods of visualization of nasal lesions have been described in the literature. We developed a new method of intraoperative endoscopy based on the intravenous administration of fluorescein. Preliminary data of this technique are reported. Methods: After the intravenous administration of sodium fluorescein, an intraoperative fluorescein-guided endoscopy was carried out using photographic customized yellow filters on top of a 0-degree, 4-mm endoscope. Results: In 2015, 65 HHT patients underwent surgery for their epistaxis in our institution, and in 7 patients (3 males, 4 females; mean age, 54 years) an intraoperative fluorescein-guided intraoperative nasal endoscopy was performed. No adverse events or complications were observed. Conclusion: First impressions regarding the usage of this technique in HHT patients seem to be promising and positive in terms of efficacy and safety. However, further studies with larger cohorts of patients should be performed in order to better investigate the use of this method for diagnostic and surgical purposes in HHT.

Original languageEnglish
Pages (from-to)300-303
Number of pages4
JournalInternational Forum of Allergy and Rhinology
Volume7
Issue number3
DOIs
Publication statusPublished - Mar 1 2017

Fingerprint

Hereditary Hemorrhagic Telangiectasia
Fluorescein
Endoscopy
Nose
Telangiectasis
Epistaxis
Intravenous Administration
Inborn Genetic Diseases
Endoscopes
Arteriovenous Malformations
Rare Diseases
Safety

Keywords

  • endoscopy
  • epistaxis
  • hemorrhagic disorders
  • hereditary
  • hereditary hemorrhagic telangiectasia
  • HHT
  • Rendu-Osler-Weber disease

ASJC Scopus subject areas

  • Immunology and Allergy
  • Otorhinolaryngology

Cite this

Fluorescein-guided intraoperative endoscopy in patients with hereditary hemorrhagic telangiectasia : first impressions. / Pagella, Fabio; Pusateri, Alessandro; Zaccari, Dario; Bongetta, Daniele; Zoia, Cesare; Spinozzi, Giuseppe; Olivieri, Carla; Matti, Elina.

In: International Forum of Allergy and Rhinology, Vol. 7, No. 3, 01.03.2017, p. 300-303.

Research output: Contribution to journalArticle

@article{9af5c2ab70d74da18d0a039a641a2525,
title = "Fluorescein-guided intraoperative endoscopy in patients with hereditary hemorrhagic telangiectasia: first impressions",
abstract = "Background: Hereditary hemorrhagic telangiectasia (HHT) is a rare genetic disease that results in mucocutaneous telangiectasias and arteriovenous visceral malformations. Nasal telangiectasias lead to recurrent epistaxis, which affects up to 96{\%} of patients. Different morphologic classifications and methods of visualization of nasal lesions have been described in the literature. We developed a new method of intraoperative endoscopy based on the intravenous administration of fluorescein. Preliminary data of this technique are reported. Methods: After the intravenous administration of sodium fluorescein, an intraoperative fluorescein-guided endoscopy was carried out using photographic customized yellow filters on top of a 0-degree, 4-mm endoscope. Results: In 2015, 65 HHT patients underwent surgery for their epistaxis in our institution, and in 7 patients (3 males, 4 females; mean age, 54 years) an intraoperative fluorescein-guided intraoperative nasal endoscopy was performed. No adverse events or complications were observed. Conclusion: First impressions regarding the usage of this technique in HHT patients seem to be promising and positive in terms of efficacy and safety. However, further studies with larger cohorts of patients should be performed in order to better investigate the use of this method for diagnostic and surgical purposes in HHT.",
keywords = "endoscopy, epistaxis, hemorrhagic disorders, hereditary, hereditary hemorrhagic telangiectasia, HHT, Rendu-Osler-Weber disease",
author = "Fabio Pagella and Alessandro Pusateri and Dario Zaccari and Daniele Bongetta and Cesare Zoia and Giuseppe Spinozzi and Carla Olivieri and Elina Matti",
year = "2017",
month = "3",
day = "1",
doi = "10.1002/alr.21880",
language = "English",
volume = "7",
pages = "300--303",
journal = "International Forum of Allergy and Rhinology",
issn = "2042-6976",
publisher = "Wiley-Blackwell",
number = "3",

}

TY - JOUR

T1 - Fluorescein-guided intraoperative endoscopy in patients with hereditary hemorrhagic telangiectasia

T2 - first impressions

AU - Pagella, Fabio

AU - Pusateri, Alessandro

AU - Zaccari, Dario

AU - Bongetta, Daniele

AU - Zoia, Cesare

AU - Spinozzi, Giuseppe

AU - Olivieri, Carla

AU - Matti, Elina

PY - 2017/3/1

Y1 - 2017/3/1

N2 - Background: Hereditary hemorrhagic telangiectasia (HHT) is a rare genetic disease that results in mucocutaneous telangiectasias and arteriovenous visceral malformations. Nasal telangiectasias lead to recurrent epistaxis, which affects up to 96% of patients. Different morphologic classifications and methods of visualization of nasal lesions have been described in the literature. We developed a new method of intraoperative endoscopy based on the intravenous administration of fluorescein. Preliminary data of this technique are reported. Methods: After the intravenous administration of sodium fluorescein, an intraoperative fluorescein-guided endoscopy was carried out using photographic customized yellow filters on top of a 0-degree, 4-mm endoscope. Results: In 2015, 65 HHT patients underwent surgery for their epistaxis in our institution, and in 7 patients (3 males, 4 females; mean age, 54 years) an intraoperative fluorescein-guided intraoperative nasal endoscopy was performed. No adverse events or complications were observed. Conclusion: First impressions regarding the usage of this technique in HHT patients seem to be promising and positive in terms of efficacy and safety. However, further studies with larger cohorts of patients should be performed in order to better investigate the use of this method for diagnostic and surgical purposes in HHT.

AB - Background: Hereditary hemorrhagic telangiectasia (HHT) is a rare genetic disease that results in mucocutaneous telangiectasias and arteriovenous visceral malformations. Nasal telangiectasias lead to recurrent epistaxis, which affects up to 96% of patients. Different morphologic classifications and methods of visualization of nasal lesions have been described in the literature. We developed a new method of intraoperative endoscopy based on the intravenous administration of fluorescein. Preliminary data of this technique are reported. Methods: After the intravenous administration of sodium fluorescein, an intraoperative fluorescein-guided endoscopy was carried out using photographic customized yellow filters on top of a 0-degree, 4-mm endoscope. Results: In 2015, 65 HHT patients underwent surgery for their epistaxis in our institution, and in 7 patients (3 males, 4 females; mean age, 54 years) an intraoperative fluorescein-guided intraoperative nasal endoscopy was performed. No adverse events or complications were observed. Conclusion: First impressions regarding the usage of this technique in HHT patients seem to be promising and positive in terms of efficacy and safety. However, further studies with larger cohorts of patients should be performed in order to better investigate the use of this method for diagnostic and surgical purposes in HHT.

KW - endoscopy

KW - epistaxis

KW - hemorrhagic disorders

KW - hereditary

KW - hereditary hemorrhagic telangiectasia

KW - HHT

KW - Rendu-Osler-Weber disease

UR - http://www.scopus.com/inward/record.url?scp=85000366257&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85000366257&partnerID=8YFLogxK

U2 - 10.1002/alr.21880

DO - 10.1002/alr.21880

M3 - Article

C2 - 27860447

AN - SCOPUS:85000366257

VL - 7

SP - 300

EP - 303

JO - International Forum of Allergy and Rhinology

JF - International Forum of Allergy and Rhinology

SN - 2042-6976

IS - 3

ER -